Labcorp Holdings Inc. (LH)
NYSE: LHHealth CareMedical SpecialitiesUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
LH stock chart
Technical analysisKey statistics
All statistics- Market cap
- $25.30B
- P/E (TTM)
- 25.80
- Forward P/E
- 15.73
- EPS (TTM)
- $12.09
- Dividend yield
- 0.92% ($2.88)
- Ex-dividend date
- Aug 28, 2026
- 52-week range
- 244.52 – 341.80
- Day range
- 311.21 – 315.09
- Volume / Avg
- 542.97K / 740.44K
- Beta
- —
- Shares outstanding
- 81.10M
- Next earnings
- Oct 28, 2026
52-week range
LH stock today
Labcorp (LH) closed at $311.97 on Oct 7, up 0.08% (+$0.26), versus the S&P 500's 0.22% decline. At this level, LH sits in the middle of its 52-week range of $244.52 to $341.80: 8.7% below the high, set on Aug 27, 2026 and 27.6% above the low. LH is up 24.4% year to date, outperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 11.6%.
At 25.8x trailing earnings, Labcorp trades in line with the peer-group median of 24.8x. Its forward P/E of 15.7x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. The company is scheduled to report Sep/2026 results on Oct 28 before the market opens; analysts expect EPS of $4.65. Labcorp pays an annual dividend of $2.88 per share, a 0.92% yield at the current price.
Summary generated from market data by MetaCap's automated system. Methodology
About Labcorp
Company profileLabcorp Holdings Inc. provides laboratory services. It operates in Diagnostics Laboratories and Biopharma Laboratory Services segments.
- Sector
- Health Care
- Industry
- Medical Specialities
- CEO
- Mr. Adam H. Schechter
- Headquarters
- Burlington, NC
- Employees
- 71,000
- Website
- labcorp.com
Financial highlights
Full financialsIn fiscal 2025, Labcorp generated $13.95 billion in revenue, up 7.2% from fiscal 2024, its 3rd consecutive year of revenue growth. Net income was $876.5 million (+17.5% year over year), for a net margin of 6.3% versus a median of 10.8% in the prior 5 years. Gross margin was 28.8% (up from 27.9%) and operating margin 9.9%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2021 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $13.95B | $13.01B | $12.16B | $11.86B | $13.14B |
| Growth | +7.25% | +6.97% | +2.51% | -9.68% | -6.03% |
| Net income | $876.50M | $746.00M | $418.00M | $1.28B | $2.38B |
| EPS (diluted) | $10.46 | $8.84 | $4.77 | $13.97 | $24.39 |
Analyst forecast
ForecastConsensus (18 analysts)
buy
Avg. price target
$344.19+10.33%
- Strong buy 2
- Buy 11
- Hold 4
- Sell 0
- Strong sell 1
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Next report
- Oct 28, 2026
- EPS estimate
- $4.65
- Last reported (Q2 2026)
- Aug 5, 2026
- EPS actual vs est.
- $3.64 vs —
Dividends
Dividend history- Annual dividend
- $2.88
- Dividend yield
- 0.92%
- Last payment
- $0.72
- Ex-dividend date
- Aug 28, 2026
LH news
All LH newsLabcorp peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| DGXQuest Diagnostics Incorporated | 227.06 | -0.58% | $25.06B | vs LH |
| GHGuardant Health Inc. | 168.33 | -1.38% | $22.59B | vs LH |
| CNCCentene Corporation | 64.99 | +0.59% | $32.10B | vs LH |
| MOHMolina Healthcare Inc | 194.82 | -0.18% | $10.17B | vs LH |
| OSCROscar Health Inc. Class A | 32.91 | +1.76% | $10.16B | vs LH |
| ILMNIllumina Inc. | 267.76 | -2.11% | $40.43B | vs LH |
| HSICHenry Schein Inc. | 83.66 | -1.39% | $9.32B | vs LH |
| CAICaris Life Sciences Inc. | 27.10 | -1.29% | $7.66B | vs LH |
Indexes, lists and sector
Index membership
Appears in lists
Labcorp stock FAQ
What is Labcorp's stock price today?
LH last traded at $311.97 as of Oct 7, 4:00 PM EDT, up 0.08% on the day. Prices are delayed at least 15 minutes.
Does Labcorp pay a dividend?
Yes. Labcorp pays $2.88 per share annually, a 0.92% yield. The most recent dividend of $0.72 had an ex-dividend date of Aug 28, 2026.
When is Labcorp's next earnings date?
Labcorp is expected to report earnings on Wednesday, October 28, 2026. Analysts expect EPS of $4.65.
What is LH's P/E ratio?
LH trades at a trailing P/E ratio of 25.80 and a forward P/E of 15.73, compared with a median of 24.8 for its closest peers.
Is Labcorp in the S&P 500?
Yes. Labcorp (LH) is a constituent of the S&P 500 index.
Who is Labcorp's CEO?
Mr. Adam H. Schechter is the chief executive officer of Labcorp Holdings Inc., which has about 71,000 employees.
Has LH ever split its stock?
Yes. The most recent LH stock split was a 1164-for-1000 split on Jul 3, 2023, one of 4 splits on record.